Skip to main content

Being in postmenopause may be associated with lower prevalence of COVID-19 symptoms among women over 45 years of age with and without HIV.

Publication ,  Journal Article
Cherenack, EM; Jones, DL; Kaminsky, C; Potter, J; Nogueira, NF; Dickerson, J; Kempf, M-C; Moran, CA; Floris-Moore, M; Topper, EF; Tien, PC ...
Published in: Menopause
July 22, 2025

OBJECTIVE: Menopause is associated with COVID-19 severity among women without HIV (WWoH). Yet, little is known about menopause and COVID-19 among women with HIV (WWH). METHODS: We conducted a cross-sectional analysis of survey data collected in 2020-2022 from WWH and WWoH over 45 years of age enrolled in the Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort Study. Women were categorized as premenopausal (no report of menstrual irregularities), perimenopausal (menstruating, with irregularities or self-reported menopause), or postmenopausal (amenorrhea for at least 1 year). Women who reported a positive COVID-19 test in any setting were asked about COVID-19 symptoms. COVID-19 symptoms during the most recent confirmed infection were compared across HIV status and menopause stage. RESULTS: Among 1,244 eligible women (70% WWH), 15% were premenopausal, 9% were perimenopausal, and 76% were postmenopausal. Among 112 women with a prior positive COVID-19 test, HIV status was not associated with COVID-19 symptoms. We combined women across HIV status and compared symptoms during premenopause/perimenopause versus postmenopause. Having any COVID-19 symptom was more common among women in premenopause/perimenopause (89%) than in postmenopause (70%). Compared with women in postmenopause, women in premenopause/perimenopause had higher odds of reporting muscle aches, fatigue, and loss of smell/taste after controlling for HIV, age, race, and ethnicity. When examining premenopause and perimenopause separately and when using alternative criteria to define menopause stage in sensitivity analyses, aches, fatigue, and loss of smell/taste remained least common in postmenopause. CONCLUSIONS: COVID-19 symptoms may be least prevalent in postmenopause and may overlap with menopause symptoms in WWH and WWoH.

Duke Scholars

Published In

Menopause

DOI

EISSN

1530-0374

Publication Date

July 22, 2025

Volume

32

Issue

12

Start / End Page

1136 / 1145

Location

United States

Related Subject Headings

  • Obstetrics & Reproductive Medicine
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cherenack, E. M., Jones, D. L., Kaminsky, C., Potter, J., Nogueira, N. F., Dickerson, J., … Alcaide, M. L. (2025). Being in postmenopause may be associated with lower prevalence of COVID-19 symptoms among women over 45 years of age with and without HIV. Menopause, 32(12), 1136–1145. https://doi.org/10.1097/GME.0000000000002618
Cherenack, Emily M., Deborah L. Jones, Chloe Kaminsky, JoNell Potter, Nicholas F. Nogueira, Jaime Dickerson, Mirjam-Colette Kempf, et al. “Being in postmenopause may be associated with lower prevalence of COVID-19 symptoms among women over 45 years of age with and without HIV.Menopause 32, no. 12 (July 22, 2025): 1136–45. https://doi.org/10.1097/GME.0000000000002618.
Cherenack EM, Jones DL, Kaminsky C, Potter J, Nogueira NF, Dickerson J, et al. Being in postmenopause may be associated with lower prevalence of COVID-19 symptoms among women over 45 years of age with and without HIV. Menopause. 2025 Jul 22;32(12):1136–45.
Cherenack, Emily M., et al. “Being in postmenopause may be associated with lower prevalence of COVID-19 symptoms among women over 45 years of age with and without HIV.Menopause, vol. 32, no. 12, July 2025, pp. 1136–45. Pubmed, doi:10.1097/GME.0000000000002618.
Cherenack EM, Jones DL, Kaminsky C, Potter J, Nogueira NF, Dickerson J, Kempf M-C, Moran CA, Floris-Moore M, Topper EF, Tien PC, Kassaye S, Minkoff H, Sharma A, Cejtin HE, Alcaide ML. Being in postmenopause may be associated with lower prevalence of COVID-19 symptoms among women over 45 years of age with and without HIV. Menopause. 2025 Jul 22;32(12):1136–1145.

Published In

Menopause

DOI

EISSN

1530-0374

Publication Date

July 22, 2025

Volume

32

Issue

12

Start / End Page

1136 / 1145

Location

United States

Related Subject Headings

  • Obstetrics & Reproductive Medicine
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences